Ignite Creation Date:
2025-12-25 @ 3:27 AM
Ignite Modification Date:
2026-03-10 @ 8:06 PM
Study NCT ID:
NCT02595905
Status:
COMPLETED
Last Update Posted:
2025-05-16
First Post:
2015-11-03
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases
Sponsor:
National Cancer Institute (NCI)
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Metastatic BRCA Hereditary Breast Carcinoma | View |
| None | Metastatic Breast Carcinoma | View |
| None | Metastatic Malignant Neoplasm in the Brain | View |
| None | Metastatic Triple-Negative Breast Carcinoma | View |
| None | Recurrent Breast Carcinoma | View |
| None | Stage IV Breast Cancer AJCC v6 and v7 | View |
Keywords: